{
    "nctId": "NCT02592980",
    "officialTitle": "Evaluation of a Pharmacogenetic-based Warfarin Dosing Algorithm in Patients With Low Time in Therapeutic Range - Study Design",
    "inclusionCriteria": "* Only patients with atrial fibrillation, above 18 years, and with TTR \\<50% based on the last three values of INR will be included in this study.\n* Must have minimum age of 18 Years",
    "exclusionCriteria": "* Patients will not be included if they have reached a stable dose of warfarin, liver dysfunction, alcoholism, use of another anticoagulant, use of chemotherapy, or if they do not meet the inclusion criteria"
}